{"database": "lobbying", "table": "lobbying_activities", "rows": [[1586989, "3131cc7d-04fd-483e-9866-114142859409", "3A", "BROWN RUDNICK LLP", 287895, "AMNEAL PHARMACEUTICALS", 2014, "third_quarter", "PHA", "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); P.L. 110 -85 relating to Risk Evaluation and Mitigation Strategy programs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2014-10-15T14:42:07.597000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1586989"], "units": {}, "query_ms": 1.8171690171584487, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}